These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37894347)

  • 1. Immunotherapy and Hypofractionated Radiotherapy in Older Patients with Locally Advanced Cutaneous Squamous-Cell Carcinoma of the Head and Neck: A Proposed Paradigm by the International Geriatric Radiotherapy Group.
    Nguyen NP; Thariat J; Gorobets O; Vinh-Hung V; Kim L; Blanco SC; Vasileiou M; Arenas M; Mazibuko T; Giap H; Vincent F; Chi A; Loganadane G; Mohammadianpanah M; Rembielak A; Karlsson U; Ali A; Bose S; Page BR
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy and Modern Radiotherapy Technique for Older Patients with Locally Advanced Head and Neck Cancer: A Proposed Paradigm by the International Geriatric Radiotherapy Group.
    Nguyen NP; Kim L; Thariat J; Baumert BG; Mazibuko T; Gorobets O; Vinh-Hung V; Giap H; Mehmood T; Vincent F; Chi A; Basu T; Loganadane G; Mohammadianpanah M; Karlsson U; Oboite E; Oboite J; Ali A; Page BR
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.
    Ashraf S; Alsharedi M
    Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma.
    Lavaud J; Blom A; Longvert C; Fort M; Funck-Brentano E; Saiag P
    Eur J Dermatol; 2019 Dec; 29(6):636-640. PubMed ID: 31903954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; van Akkooi A; Bataille V; Bastholt L; Dreno B; Dummer R; Fargnoli MC; Forsea AM; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Lallas A; Leiter U; Malvehy J; Del Marmol V; Moreno-Ramirez D; Pellacani G; Peris K; Saiag P; Tagliaferri L; Trakatelli M; Ioannides D; Vieira R; Zalaudek I; Arenberger P; Eggermont AMM; Röcken M; Grob JJ; Lorigan P;
    Eur J Cancer; 2023 Nov; 193():113252. PubMed ID: 37708630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous squamous-cell carcinoma of the head-neck area refractory to chemo-radiotherapy: benefit from anti-PD-1 immunotherapy.
    Koukourakis IM; Giakzidis AG; Kouroupi M; Giatromanolaki A; Abatzoglou I; Karpouzis A; Koukourakis MI
    BJR Case Rep; 2021 May; 7(3):20200170. PubMed ID: 34131497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab.
    Stevenson ML; Wang CQ; Abikhair M; Roudiani N; Felsen D; Krueger JG; Pavlick AC; Carucci JA
    JAMA Dermatol; 2017 Apr; 153(4):299-303. PubMed ID: 28259107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region.
    De Felice F; Musio D; Tombolini V
    Radiol Med; 2021 Apr; 126(4):620-622. PubMed ID: 33058025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy and radiotherapy for older patients with locally advanced rectal cancer unfit for surgery or decline surgery: a practical proposal by the International Geriatric Radiotherapy Group.
    Nguyen NP; Mohammadianpanah M; SunMyint A; Page BR; Vinh-Hung V; Gorobets O; Arenas M; Mazibuko T; Giap H; Vasileiou M; Dutheil F; Tuscano C; Karlsson UL; Dahbi Z; Natoli E; Li E; Kim L; Oboite J; Oboite E; Bose S; Vuong T
    Front Oncol; 2024; 14():1325610. PubMed ID: 38463223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma.
    Khorasanchi A; Wu R; Kendra K; Verschraegen C
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is immunotherapy at reduced dose and radiotherapy for older patients with locally advanced non-small lung cancer feasible?-a narrative review by the international geriatric radiotherapy group.
    Vinh-Hung V; Gorobets O; Duerinkcx A; Dutta S; Oboite E; Oboite J; Ali A; Mazibuko T; Karlsson U; Chi A; Lehrman D; Mohammed OH; Mohammadianpanah M; Loganadane G; Migliore N; Vasileiou M; Nguyen NP; Giap H
    Transl Cancer Res; 2022 Sep; 11(9):3298-3308. PubMed ID: 36237270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from Israel.
    Averbuch I; Salman S; Shtamper N; Doweck I; Popovtzer A; Markel G; Hendler D; Finkel I; Moore A; Fenig E; Taha T; Mhameed K; Kurman N; Billan S
    Front Oncol; 2023; 13():1117804. PubMed ID: 36793605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Perineural Invasion and Immunotherapy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Wu MP; Reinshagen KL; Cunnane MB; Shalhout SZ; Kaufman HL; Miller D; Emerick KS
    Laryngoscope; 2022 Jun; 132(6):1213-1218. PubMed ID: 34797598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
    Giralt J; Trigo J; Nuyts S; Ozsahin M; Skladowski K; Hatoum G; Daisne JF; Yunes Ancona AC; Cmelak A; Mesía R; Zhang A; Oliner KS; VanderWalde A
    Lancet Oncol; 2015 Feb; 16(2):221-32. PubMed ID: 25596659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials.
    Poulose JV; Kainickal CT
    World J Clin Oncol; 2022 May; 13(5):388-411. PubMed ID: 35662989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
    Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
    Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and emerging drugs for the treatment of advanced cutaneous squamous cell carcinoma.
    Bonini F; de Sousa LG; Ferrarotto R
    Expert Opin Emerg Drugs; 2023 Dec; 28(2):97-106. PubMed ID: 37144289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement.
    Lopetegui-Lia N; Dima D; Buchberger DS; Yalamanchali A; Osantowski B; Ondeck M; Lorenz RR; Prendes B; Ku J; Lamarre E; Scharpf J; Silver NL; Schwartzman L; Geiger JL; Woody NM; Campbell SR; Koyfman SA; Yilmaz E
    Head Neck; 2023 Aug; 45(8):2149-2154. PubMed ID: 37272705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of recurrent cutaneous squamous cell carcinoma of the head and neck after definitive surgery and radiotherapy.
    Toppi J; Tham YS; Webb A; Henderson MA; Rischin D; Magarey MJR
    ANZ J Surg; 2020 Jul; 90(7-8):1391-1395. PubMed ID: 32627359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: The Current and Future Role of Radiation Therapy in the Era of Immunotherapy.
    Ferini G; Palmisciano P; Forte S; Viola A; Martorana E; Parisi S; Valenti V; Fichera C; Umana GE; Pergolizzi S
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.